Editorial
doi: 10.1161/CIRCINTERVENTIONS.122.012261.
Epub 2022 Jul 28.
Still a Long Way to the Precision Medicine of Antiplatelet Strategy After Percutaneous Coronary Intervention
Affiliations
- PMID: 35899617
- DOI: 10.1161/CIRCINTERVENTIONS.122.012261
Item in Clipboard
Editorial
Still a Long Way to the Precision Medicine of Antiplatelet Strategy After Percutaneous Coronary Intervention
Circ Cardiovasc Interv.
2022 Aug.
No abstract available
Keywords: Editorials; acute coronary syndrome; aspirin; blood platelets; precision medicine; purinergic P2Y receptor antagonists.
Comment on
-
Comparison of Unguided De-Escalation Versus Guided Selection of Dual Antiplatelet Therapy After Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis.Circ Cardiovasc Interv. 2022 Aug;15(8):e011990. doi: 10.1161/CIRCINTERVENTIONS.122.011990. Epub 2022 Jul 28. Circ Cardiovasc Interv. 2022. PMID: 35899618
Similar articles
-
Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention.Circulation. 2016 May 24;133(21):2094-8. doi: 10.1161/CIRCULATIONAHA.115.021158. Circulation. 2016. PMID: 27217435 Review. No abstract available.
-
Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors.Eur Heart J Cardiovasc Pharmacother. 2017 Oct 1;3(4):221-234. doi: 10.1093/ehjcvp/pvw044. Eur Heart J Cardiovasc Pharmacother. 2017. PMID: 28204303 Review.
-
Clopidogrel: the data, the experience, and the controversies.Am J Cardiovasc Drugs. 2012 Dec 1;12(6):361-74. doi: 10.2165/11636340-000000000-00000. Am J Cardiovasc Drugs. 2012. PMID: 23057989 Review.
-
Long-Term P2Y12 Inhibitor or Aspirin as Single Antiplatelet Therapy in Patients With Previous Percutaneous Coronary Intervention.Circulation. 2023 Jan 10;147(2):118-121. doi: 10.1161/CIRCULATIONAHA.122.063004. Epub 2023 Jan 9. Circulation. 2023. PMID: 36622905 No abstract available.
-
Individualized dual antiplatelet therapy based on platelet function testing in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials.BMC Cardiovasc Disord. 2017 Jun 15;17(1):157. doi: 10.1186/s12872-017-0582-6. BMC Cardiovasc Disord. 2017. PMID: 28619104 Free PMC article.
Cited by
-
Do coronary stent policies affect the cost-effectiveness of percutaneous coronary intervention among patients with acute coronary syndrome in Shanghai? A retrospective cohort study based on real-world and propensity score-matched data.BMJ Open. 2024 Jun 19;14(6):e083456. doi: 10.1136/bmjopen-2023-083456. BMJ Open. 2024. PMID: 38904127 Free PMC article.
-
The effect of coronary stent policies on the risk of percutaneous coronary intervention among acute coronary syndrome patients in Shanghai: Real-world evidence.PLoS One. 2024 Apr 1;19(4):e0301448. doi: 10.1371/journal.pone.0301448. eCollection 2024. PLoS One. 2024. PMID: 38557900 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
